Director/PDMR Shareholding

RNS Number : 8818R

Yourgene Health PLC

01 November 2019

 

 Yourgene Health plc

("Yourgene Health" or the "Company")

Director / PDMR Shareholding

Manchester, UK - 1 November 2019: Yourgene Health (AIM: YGEN), a leading international molecular diagnostics group, announces that it was notified yesterday that Dr John Brown, Senior Independent Director of the Company, purchased 100,000 ordinary shares of 0.10p each in the Company yesterday at a price of 11.5 pence per ordinary share, representing 0.02% of the Company's issued share capital, via a pension fund held in his name.

Prior to the purchase, Dr John Brown did not hold any ordinary shares nor options in the Company.

This announcement contains inside information for the purposes of Article 7 of EU Regulation 596/2014.

Yourgene Health plc Lyn Rees, Chief Executive Officer Barry Hextall, Chief Financial Officer Joanne Cross, Director of Marketing	Tel: [phone] [e-mail]
Cairn Financial Advisers LLP (NOMAD) Liam Murray / James Caithie / Ludovico Lazzaretti	Tel: [phone]
Stifel Nicolaus Europe Limited (Sole Corporate Broker) Nicholas Moore / Matthew Blawat / Ben Maddison		Tel: [phone]
Walbrook PR Ltd (Media and Investor Relations) Lianne Cawthorne / Alice Woodings	Tel: [phone] or [e-mail] Mob: [phone]

About Yourgene Health

Yourgene Health is an international molecular diagnostics group which develops and commercialises genetic products and services. The group works in partnership with global leaders in DNA technology to advance diagnostic science. 

Yourgene develops and commercialises simple and accurate molecular diagnostic solutions, primarily for reproductive health. The Group's products include non-invasive prenatal tests (NIPT) for Down's Syndrome and other genetic disorders, Cystic Fibrosis screening tests, invasive rapid aneuploidy tests, male infertility tests and genetic disease tests. Yourgene's commercial footprint is already established in the UK, Europe, the Middle East, Africa and Asia.

Our product development, research service and commercial capabilities extend across the lifecycle of genetic test development including regulatory submissions. Through our technical expertise and partnerships, Yourgene Health is also extending its genetic testing offering into oncology.

Yourgene Health is headquartered in Manchester, UK with offices in Taipei and Singapore, and is listed on the London Stock Exchange's AIM market under the ticker "YGEN". For more information visit www.yourgene-health.com and follow us on twitter @Yourgene_Health.

Notification of a Transaction pursuant to Article 19(1) of Regulation (EU) No. 596/2014
1	Details of the person discharging managerial responsibilities/person closely associated
a.	Name	Dr John Brown
2	Reason for notification
a.	Position/Status	Senior Independent Director
b.	Initial notification/ Amendment	Initial notification
3	Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
a.	Name	Yourgene Health plc
b.	LEI	213800UUIT8BZE7QEH33
4	Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a.	Description of the financial instrument, type of instrument Identification Code	Ordinary shares of 0.1p each ISIN: GB00BN31ZD89
b.	Nature of the transaction	Purchase
c.	Price(s) and volume(s)
			Price(s)	Volume(s)
			11.5p	100,000
e.	Date of the transaction	31 October 2019
f.	Place of the transaction	UK

 

END

 

 

DSHDFLFXKBFBFBV